Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12-week, Multicenter, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster® NEXThaler® (Beclomethasone Dipropionate 100 µg Plus Formoterol 6 µg/Actuation), 2 Inhalations b.i.d., Versus Seretide® Accuhaler® (Fluticasone 250 µg Plus Salmeterol 50 µg/Actuation), 1 Inhalation b.i.d., on Small Airway Derived Parameters in Patients With Asthma
Brief Summary: The purpose of the present study is to demonstrate the higher efficacy of Foster® NEXThaler® 100/6 extra fine (two inhalations b.i.d.) versus Seretide® Accuhaler® 250/50 (one inhalation b.i.d.), in terms of pulmonary function (change from baseline to the end of treatment in post-dose peripheral airway resistance) in patients with asthma.


Options:
A: Arm Label: Foster® NEXThaler®; Type: EXPERIMENTAL; Interventions: Drug: Foster® NEXThaler® 100/6 µg/unit dose | Arm Label: Seretide® Accuhaler®; Type: ACTIVE_COMPARATOR; Interventions: Drug: Seretide® Accuhaler® 250/50 µg/actuation | Intervention Type: DRUG; Name: Foster® NEXThaler® 100/6 µg/unit dose; Assigned to Arm(s): Foster® NEXThaler® | Intervention Type: DRUG; Name: Seretide® Accuhaler® 250/50 µg/actuation; Assigned to Arm(s): Seretide® Accuhaler®
B: Intervention Type: DRUG; Name: FLUTIFORM® (Formoterol fumarate / Fluticasone propionate); Assigned to Arm(s): N/A
C: Arm Label: Fluticasone Furoate/Vilanterol; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate, Drug: Vilanterol | Arm Label: FP/S OR BUD/F; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone propionate, Drug: Salmeterol, Drug: Budesonide, Drug: Formoterol Fumarate | Intervention Type: DRUG; Name: Fluticasone Furoate; Assigned to Arm(s): Fluticasone Furoate/Vilanterol | Intervention Type: DRUG; Name: Vilanterol; Assigned to Arm(s): Fluticasone Furoate/Vilanterol | Intervention Type: DRUG; Name: Fluticasone propionate; Assigned to Arm(s): FP/S OR BUD/F | Intervention Type: DRUG; Name: Salmeterol; Assigned to Arm(s): FP/S OR BUD/F | Intervention Type: DRUG; Name: Budesonide; Assigned to Arm(s): FP/S OR BUD/F | Intervention Type: DRUG; Name: Formoterol Fumarate; Assigned to Arm(s): FP/S OR BUD/F
D: Arm Label: FS MDPI 100 / 12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: FS MDPI 50 / 12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: Fp MDPI 100 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: Fp MDPI 50 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: Placebo MDPI; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Intervention Type: DRUG; Name: FS MDPI; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 50 / 12.5 mcg | Intervention Type: DRUG; Name: Fp MDPI; Assigned to Arm(s): Fp MDPI 100 mcg, Fp MDPI 50 mcg | Intervention Type: DRUG; Name: Placebo MDPI; Assigned to Arm(s): Placebo MDPI | Intervention Type: DRUG; Name: albuterol/salbutamol; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 50 / 12.5 mcg, Fp MDPI 100 mcg, Fp MDPI 50 mcg, Placebo MDPI | Intervention Type: DRUG; Name: Beclomethasone dipropionate; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 50 / 12.5 mcg, Fp MDPI 100 mcg, Fp MDPI 50 mcg, Placebo MDPI

Answer: A